This page shows Vita Coco Company, Inc. (COCO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Vita Coco's economics improved materially, but growth now ties up more cash in inventory and receivables than in factories or debt.
In FY2025, operating cash flow was only$47.2M against net income of$72.7M , so reported profit did not fully turn into cash. That shortfall fits a working-capital build, with inventory at$111.5M and receivables at$81.5M , meaning growth currently consumes cash before it releases it.
The balance sheet is unusually liquid: cash reached
The margin story is not simple price-led expansion: gross margin eased from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Vita Coco Company, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Vita Coco Company, Inc. has an operating margin of 13.5%, meaning the company retains $14 of operating profit per $100 of revenue. This strong profitability earns a score of 69/100, reflecting efficient cost management and pricing power. This is down from 14.3% the prior year.
Vita Coco Company, Inc.'s revenue surged 18.2% year-over-year to $609.8M, reflecting rapid business expansion. This strong growth earns a score of 68/100.
Vita Coco Company, Inc. has a moderate D/E ratio of 0.39. This balance of debt and equity financing earns a leverage score of 64/100.
With a current ratio of 3.62, Vita Coco Company, Inc. holds $3.62 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 83/100.
Vita Coco Company, Inc. converts 6.4% of revenue into free cash flow ($39.0M). This strong cash generation earns a score of 67/100.
Vita Coco Company, Inc. earns a strong 21.9% return on equity (ROE), meaning it generates $22 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 82/100. This is up from 21.6% the prior year.
Vita Coco Company, Inc. scores 21.49, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($3.9B) relative to total liabilities ($129.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Vita Coco Company, Inc. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Vita Coco Company, Inc. generates $0.65 in operating cash flow ($47.2M OCF vs $72.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
Vita Coco Company, Inc. generated $609.8M in revenue in fiscal year 2025. This represents an increase of 18.2% from the prior year.
Vita Coco Company, Inc.'s EBITDA was $83.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 12.1% from the prior year.
Vita Coco Company, Inc. reported $72.7M in net income in fiscal year 2025. This represents an increase of 29.9% from the prior year.
Vita Coco Company, Inc. earned $1.19 per diluted share (EPS) in fiscal year 2025. This represents an increase of 26.6% from the prior year.
Cash & Balance Sheet
Vita Coco Company, Inc. generated $39.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 6.9% from the prior year.
Vita Coco Company, Inc. held $196.9M in cash against $0 in long-term debt as of fiscal year 2025.
Vita Coco Company, Inc. had 57M shares outstanding in fiscal year 2025. This represents an increase of 0.2% from the prior year.
Margins & Returns
Vita Coco Company, Inc.'s gross margin was 36.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.0 percentage points from the prior year.
Vita Coco Company, Inc.'s operating margin was 13.5% in fiscal year 2025, reflecting core business profitability. This is down 0.8 percentage points from the prior year.
Vita Coco Company, Inc.'s net profit margin was 11.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.1 percentage points from the prior year.
Vita Coco Company, Inc.'s ROE was 21.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.3 percentage points from the prior year.
Capital Allocation
Vita Coco Company, Inc. invested $399K in research and development in fiscal year 2025. This represents an increase of 0.3% from the prior year.
Vita Coco Company, Inc. spent $11.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 6.3% from the prior year.
Vita Coco Company, Inc. invested $8.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 736.7% from the prior year.
COCO Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $179.8M+40.7% | $127.8M-29.9% | $182.3M+8.0% | $168.8M+28.9% | $130.9M+2.9% | $127.3M-4.2% | $132.9M-7.8% | $144.1M |
| Cost of Revenue | $108.0M+29.7% | $83.2M-26.8% | $113.6M+5.7% | $107.5M+29.8% | $82.8M-3.7% | $86.0M+5.7% | $81.3M-4.7% | $85.4M |
| Gross Profit | $71.8M+61.1% | $44.6M-35.1% | $68.7M+12.1% | $61.3M+27.4% | $48.1M+16.4% | $41.3M-19.9% | $51.6M-12.2% | $58.7M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $38.2M+11.2% | $34.4M-15.6% | $40.7M+12.7% | $36.1M+25.5% | $28.8M-22.2% | $37.0M+19.6% | $31.0M+7.7% | $28.8M |
| Operating Income | $33.6M+229.4% | $10.2M-63.5% | $27.9M+11.1% | $25.1M+30.2% | $19.3M+350.2% | $4.3M-79.2% | $20.6M-31.3% | $30.0M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | $0 | $0 | $0 |
| Income Tax | $7.0M+64.7% | $4.2M-36.6% | $6.7M+26.8% | $5.3M-4.0% | $5.5M+418.8% | -$1.7M-127.0% | $6.4M-0.8% | $6.4M |
| Net Income | $30.5M+343.1% | $6.9M-71.3% | $24.0M+4.8% | $22.9M+21.3% | $18.9M+460.6% | $3.4M-82.5% | $19.3M+0.8% | $19.1M |
| EPS (Diluted) | $0.50 | N/A | $0.40+5.3% | $0.38+22.6% | $0.31 | N/A | $0.320.0% | $0.32 |
COCO Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $488.3M+5.9% | $461.2M0.0% | $461.3M+9.6% | $421.1M+9.7% | $384.0M+6.0% | $362.4M+2.6% | $353.1M+9.3% | $323.0M |
| Current Assets | $449.7M+6.7% | $421.4M-0.4% | $423.3M+9.5% | $386.7M+10.0% | $351.5M+3.0% | $341.3M+3.2% | $330.8M+10.0% | $300.6M |
| Cash & Equivalents | $201.9M+2.6% | $196.9M-3.4% | $203.7M+21.9% | $167.0M+8.7% | $153.6M-6.7% | $164.7M+5.1% | $156.7M+4.4% | $150.1M |
| Inventory | $86.4M-22.5% | $111.5M+32.0% | $84.4M+0.4% | $84.1M-4.8% | $88.3M+5.7% | $83.6M+28.8% | $64.9M+42.8% | $45.5M |
| Accounts Receivable | $120.8M+48.2% | $81.5M-21.2% | $103.4M+0.8% | $102.6M+33.6% | $76.8M+21.0% | $63.5M-19.3% | $78.6M-0.4% | $78.9M |
| Goodwill | $7.8M0.0% | $7.8M0.0% | $7.8M0.0% | $7.8M0.0% | $7.8M0.0% | $7.8M0.0% | $7.8M0.0% | $7.8M |
| Total Liabilities | $136.2M+5.1% | $129.6M-5.8% | $137.6M+10.8% | $124.1M+17.0% | $106.1M+2.5% | $103.6M+2.5% | $101.0M+11.0% | $91.0M |
| Current Liabilities | $123.2M+5.8% | $116.4M-5.7% | $123.5M+12.2% | $110.0M+17.9% | $93.4M-9.6% | $103.3M+2.5% | $100.7M+10.9% | $90.8M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $352.2M+6.2% | $331.5M+2.4% | $323.7M+9.0% | $296.9M+6.9% | $277.9M+7.4% | $258.8M+2.7% | $252.1M+8.7% | $232.0M |
| Retained Earnings | $258.5M+13.4% | $228.0M+2.5% | $222.5M+12.1% | $198.5M+13.0% | $175.6M+12.1% | $156.7M+2.2% | $153.3M+14.4% | $134.1M |
COCO Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $15.6M+500.5% | -$3.9M-110.0% | $39.1M+79.1% | $21.8M+322.6% | -$9.8M-241.6% | $6.9M-25.8% | $9.3M-65.4% | $26.9M |
| Capital Expenditures | $461K-85.7% | $3.2M-5.4% | $3.4M+259.6% | $949K+69.8% | $559K+347.2% | $125K-71.3% | $435K+50.0% | $290K |
| Free Cash Flow | $15.1M+312.5% | -$7.1M-120.0% | $35.6M+70.9% | $20.9M+301.4% | -$10.4M-252.4% | $6.8M-23.5% | $8.9M-66.6% | $26.6M |
| Investing Cash Flow | -$461K+86.2% | -$3.3M+2.4% | -$3.4M-259.6% | -$949K-69.8% | -$559K-347.2% | -$125K+71.3% | -$435K-50.0% | -$290K |
| Financing Cash Flow | -$9.9M-2594.2% | $397K-65.5% | $1.1M+114.4% | -$8.0M-626.3% | -$1.1M-153.1% | $2.1M+214.8% | -$1.8M-443.9% | $524K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $11.5M+980.3% | $1.1M+605.3% | $151K-98.2% | $8.6M+469.8% | $1.5M | $0-100.0% | $2.8M | $0 |
COCO Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 40.0%+5.1pp | 34.9%-2.8pp | 37.7%+1.4pp | 36.3%-0.4pp | 36.7%+4.3pp | 32.5%-6.3pp | 38.8%-2.0pp | 40.8% |
| Operating Margin | 18.7%+10.7pp | 8.0%-7.3pp | 15.3%+0.4pp | 14.9%+0.2pp | 14.7%+11.4pp | 3.4%-12.1pp | 15.5%-5.3pp | 20.8% |
| Net Margin | 17.0%+11.6pp | 5.4%-7.8pp | 13.2%-0.4pp | 13.6%-0.9pp | 14.4%+11.8pp | 2.6%-11.8pp | 14.5%+1.2pp | 13.3% |
| Return on Equity | 8.6%+6.6pp | 2.1%-5.3pp | 7.4%-0.3pp | 7.7%+0.9pp | 6.8%+5.5pp | 1.3%-6.3pp | 7.6%-0.6pp | 8.2% |
| Return on Assets | 6.2%+4.8pp | 1.5%-3.7pp | 5.2%-0.2pp | 5.4%+0.5pp | 4.9%+4.0pp | 0.9%-4.5pp | 5.5%-0.5pp | 5.9% |
| Current Ratio | 3.65+0.0 | 3.62+0.2 | 3.43-0.1 | 3.51-0.3 | 3.76+0.5 | 3.31+0.0 | 3.28-0.0 | 3.31 |
| Debt-to-Equity | 0.390.0 | 0.39-0.0 | 0.420.0 | 0.42+0.0 | 0.38-0.0 | 0.400.0 | 0.400.0 | 0.39 |
| FCF Margin | 8.4%+14.0pp | -5.6%-25.1pp | 19.6%+7.2pp | 12.4%+20.3pp | -7.9%-13.3pp | 5.3%-1.3pp | 6.7%-11.8pp | 18.5% |
Similar Companies
Frequently Asked Questions
What is Vita Coco Company, Inc.'s annual revenue?
Vita Coco Company, Inc. (COCO) reported $609.8M in total revenue for fiscal year 2025. This represents a 18.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Vita Coco Company, Inc.'s revenue growing?
Vita Coco Company, Inc. (COCO) revenue grew by 18.2% year-over-year, from $516.0M to $609.8M in fiscal year 2025.
Is Vita Coco Company, Inc. profitable?
Yes, Vita Coco Company, Inc. (COCO) reported a net income of $72.7M in fiscal year 2025, with a net profit margin of 11.9%.
What is Vita Coco Company, Inc.'s EBITDA?
Vita Coco Company, Inc. (COCO) had EBITDA of $83.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Vita Coco Company, Inc.'s gross margin?
Vita Coco Company, Inc. (COCO) had a gross margin of 36.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Vita Coco Company, Inc.'s operating margin?
Vita Coco Company, Inc. (COCO) had an operating margin of 13.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Vita Coco Company, Inc.'s net profit margin?
Vita Coco Company, Inc. (COCO) had a net profit margin of 11.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Vita Coco Company, Inc.'s return on equity (ROE)?
Vita Coco Company, Inc. (COCO) has a return on equity of 21.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Vita Coco Company, Inc.'s free cash flow?
Vita Coco Company, Inc. (COCO) generated $39.0M in free cash flow during fiscal year 2025. This represents a -6.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Vita Coco Company, Inc.'s operating cash flow?
Vita Coco Company, Inc. (COCO) generated $47.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Vita Coco Company, Inc.'s total assets?
Vita Coco Company, Inc. (COCO) had $461.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Vita Coco Company, Inc.'s capital expenditures?
Vita Coco Company, Inc. (COCO) invested $8.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Vita Coco Company, Inc. spend on research and development?
Vita Coco Company, Inc. (COCO) invested $399K in research and development during fiscal year 2025.
What is Vita Coco Company, Inc.'s current ratio?
Vita Coco Company, Inc. (COCO) had a current ratio of 3.62 as of fiscal year 2025, which is generally considered healthy.
What is Vita Coco Company, Inc.'s debt-to-equity ratio?
Vita Coco Company, Inc. (COCO) had a debt-to-equity ratio of 0.39 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Vita Coco Company, Inc.'s return on assets (ROA)?
Vita Coco Company, Inc. (COCO) had a return on assets of 15.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Vita Coco Company, Inc.'s Altman Z-Score?
Vita Coco Company, Inc. (COCO) has an Altman Z-Score of 21.49, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Vita Coco Company, Inc.'s Piotroski F-Score?
Vita Coco Company, Inc. (COCO) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Vita Coco Company, Inc.'s earnings high quality?
Vita Coco Company, Inc. (COCO) has an earnings quality ratio of 0.65x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Vita Coco Company, Inc.?
Vita Coco Company, Inc. (COCO) scores 72 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.